Tag: latephase
Merck KGaA suffers major blow as multiple sclerosis drug fails in late-phase trials – 12/05/2023 at 11:03 p.m.
(Rewrites on all levels) by Ludwig Burger Germany’s Merck KGaA MRCG.DE said its experimental multiple sclerosis drug evobrutinib failed to meet the primary goal in highly anticipated late-stage trials, dealing…
Merck KGaA suffers major blow as multiple sclerosis drug fails in late-phase trials – 06/12/2023 at 00:00
(Adds details on pharmaceutical unit results in paragraph 12, as well as information on group performance in last two paragraphs) by Ludwig Burger Germany’s Merck KGaA MRCG.DE said its experimental…